BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 29616847)

  • 21. Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review.
    Rhee JY; Tremblay D; Chan AM; Tallman MS; Mascarenhas J
    Blood Adv; 2019 Jun; 3(12):1854-1857. PubMed ID: 31213431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful treatment of acute promyelocytic leukemia in pregnancy with single-agent all-trans retinoic acid.
    Nellessen CM; Janzen V; Mayer K; Giovannini G; Gembruch U; Brossart P; Merz WM
    Arch Gynecol Obstet; 2018 Feb; 297(2):281-284. PubMed ID: 29110117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Therapeutically Related Drugs on Coagulation-Anticoagulation Balance in Acute Promyelocytic Leukemia.
    Xiao M; Zhou P; Sun K
    Clin Appl Thromb Hemost; 2022; 28():10760296221080166. PubMed ID: 35187963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curative strategies in APL.
    Iland HJ
    Semin Hematol; 2019 Apr; 56(2):131-138. PubMed ID: 30926089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide?
    Tsimberidou AM; Kantarjian H; Keating MJ; Estey E
    Leuk Lymphoma; 2006 Nov; 47(11):2282-8. PubMed ID: 17107899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation syndrome in acute promyelocytic leukaemia.
    Stahl M; Tallman MS
    Br J Haematol; 2019 Oct; 187(2):157-162. PubMed ID: 31410848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All trans retinoic acid treatment for patients with acute promyelocytic leukemia.
    Fenaux P; Castaigne S; Chomienne C; Dombret H; Degos L
    Leukemia; 1992; 6 Suppl 1():64-6. PubMed ID: 1548938
    [No Abstract]   [Full Text] [Related]  

  • 28. The simpler, the better: oral arsenic for acute promyelocytic leukemia.
    Zhu HH; Hu J; Lo-Coco F; Jin J
    Blood; 2019 Aug; 134(7):597-605. PubMed ID: 31113776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation therapy revisited.
    de Thé H
    Nat Rev Cancer; 2018 Feb; 18(2):117-127. PubMed ID: 29192213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid.
    Burry LD; Seki JT
    Ann Pharmacother; 2002 Dec; 36(12):1900-6. PubMed ID: 12452754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic trioxide as a novel anti-glioma drug: a review.
    Fang Y; Zhang Z
    Cell Mol Biol Lett; 2020; 25():44. PubMed ID: 32983240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.
    Iland HJ; Wei A; Seymour JF
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):39-52. PubMed ID: 24907016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia.
    Soignet SL
    Oncologist; 2001; 6 Suppl 2():11-6. PubMed ID: 11331435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide.
    Slack JL; Waxman S; Tricot G; Tallman MS; Bloomfield CD
    Oncologist; 2002; 7 Suppl 1():1-13. PubMed ID: 11961204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arsenic efficient in acute promyelocytic leukemia].
    Lehmann S; Paul C
    Lakartidningen; 1999 Dec; 96(50):5626-8. PubMed ID: 10643228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arsenic trioxide, a new drug for the treatment of acute promyelocytic leukemia resistant to tretinoine].
    Haanen C; Vermes I
    Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1738-41. PubMed ID: 10494320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2. All-trans retinoic acid in the treatment of acute promyelocytic leukemia.
    Asou N
    Intern Med; 2007; 46(2):91-3. PubMed ID: 17220606
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute promyelocytic leukaemia in the all trans retinoic acid era.
    DeLoughery TG; Goodnight SH
    Med Oncol; 1996 Dec; 13(4):233-40. PubMed ID: 9152974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.
    Tallman MS
    Leukemia; 1998 Sep; 12 Suppl 1():S37-40. PubMed ID: 9777894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia.
    Zhang P
    J Biol Regul Homeost Agents; 1999; 13(4):195-200. PubMed ID: 10703942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.